UTHRUnited Therapeutics Corp

CSNasdaq (XNAS)·USD

Identity

Security key: 23162
Ticker: UTHR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1999-06-17
Round lot: 40
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: UTHR

Detail

Enriched 2026-08-14 20:47

Market cap: $21,948,024,910.24
Shares outstanding (class): 42,890,692
Shares outstanding (weighted): 42,890,692
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 1,400
Location: SILVER SPRING, MD
Homepage: https://www.unither.com
Description: United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Market cap and share counts drift.

Funds holding this security

348 funds · 353 positions · $5.87B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Mid-Cap ETF iShares Trust	IJH	$845.29M	0.80%	1,425,491 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$825.74M	0.04%	1,392,532 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$599.25M	0.36%	1,010,571 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$381.60M	0.63%	643,525 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$284.99M	0.35%	480,606 NS	FIGI
State Street SPDR S&P MidCap 400SM ETF Trust —	—	$192.44M	0.79%	324,529 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$187.09M	2.30%	315,509 NS	FIGI
iShares S&P Mid-Cap 400 Growth ETF iShares Trust	IJK	$155.23M	1.57%	261,785 NS	FIGI
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust	—	$154.81M	1.38%	261,071 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$146.43M	1.34%	246,943 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 400(TM) M… SPDR SERIES TRUST	SPMD	$124.74M	0.80%	210,359 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$98.94M	4.36%	166,849 NS	FIGI
iShares Russell Mid-Cap ETF iShares Trust	IWR	$96.21M	0.20%	162,241 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$92.23M	1.24%	155,530 NS	FIGI
Franklin Dynatech Fund Franklin Custodian Funds	—	$88.95M	0.36%	150,000 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERUTHR
FIGI_COMPOSITEBBG000BV4XJ1
FIGI_SHARE_CLASSBBG001S8RV10
CIK0001082554
ISINUS91307C1027
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: United Therapeutics is a biopharmaceutical company focused on treatments for pulmonary arterial hypertension, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.